These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1377837)
41. Brain acetylcholine mediates the hypertensive response to physostigmine in the rat. Brezenoff HE; Rusin J Eur J Pharmacol; 1974 Dec; 29(2):262-6. PubMed ID: 4442444 [No Abstract] [Full Text] [Related]
42. Acetylcholine in the posterior hypothalamic nucleus is involved in the elevated blood pressure in the spontaneously hypertensive rat. Brezenoff HE; Xiao YF Life Sci; 1989; 45(13):1163-70. PubMed ID: 2796602 [TBL] [Abstract][Full Text] [Related]
43. Central noradrenergic pathways are not involved in the pressor response to intracerebroventricular substance P. Badoer E; Würth H; Qadri F; Itoi K; Unger T Eur J Pharmacol; 1988 Sep; 154(1):105-8. PubMed ID: 2460363 [TBL] [Abstract][Full Text] [Related]
44. Surgical stress inhibits physostigmine-induced pressor effect. Oktay S; Onur R; Ilhan M; Kayaalp SO Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):237-42. PubMed ID: 3789886 [TBL] [Abstract][Full Text] [Related]
45. Substance P evokes bradycardia by stimulation of postganglionic cholinergic neurons. Tompkins JD; Hoover DB; Hancock JC Peptides; 1999; 20(5):623-8. PubMed ID: 10465515 [TBL] [Abstract][Full Text] [Related]
46. Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl. Laubie M; Schmitt H; Canellas J; Roquebert J; Demichel P Eur J Pharmacol; 1974 Sep; 28(1):66-75. PubMed ID: 4154206 [No Abstract] [Full Text] [Related]
47. Cardiovascular effects of synthetic substance P. Pham-Huu-Chanh ; Pham-Huu-Chanh A; Clavel P; Lehmann-Schad W Pharmacology; 1977; 15(4):341-7. PubMed ID: 896951 [TBL] [Abstract][Full Text] [Related]
48. The effect of physostigmine on the haemorrhagic hypovolemia in anaesthetized rabbits. Savić J; Varagić VM; Prostran MS; Vujnov S; Mihajlović M; Djurdjević D Gen Pharmacol; 1992 Mar; 23(2):221-4. PubMed ID: 1639236 [TBL] [Abstract][Full Text] [Related]
49. Central cardiovascular effects of physostigmine in humans. Janowsky DS; Risch SC; Huey LY Hypertension; 1985; 7(1):140-5. PubMed ID: 3980055 [TBL] [Abstract][Full Text] [Related]
51. Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rate. Laubie M; Delbarre B; Bogaievsky D; Bogaievsky Y; Tsoucaris-Kupfer D; Senon D; Schmitt H; Schmitt H Circ Res; 1976 Jun; 38(6 Suppl 2):35-41. PubMed ID: 5206 [No Abstract] [Full Text] [Related]
52. Effect of naloxone on physostigmine-induced pressor response in adrenalectomized rats. Oktay S; Onur R; Ilhan M; Kayaalp SO Arch Int Physiol Biochim; 1987 Jun; 95(2):141-5. PubMed ID: 2444181 [TBL] [Abstract][Full Text] [Related]
53. Physostigmine has a life-saving effect in rats subjected to prolonged respiratory arrest. Guarini S; Bazzani C; Bertolini A Neurosci Lett; 1997 Sep; 232(3):123-6. PubMed ID: 9310295 [TBL] [Abstract][Full Text] [Related]
54. Central anticholinergic actions of doxepin in rabbits. Moore RH; White RP Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):113-20. PubMed ID: 1156010 [TBL] [Abstract][Full Text] [Related]
55. Relationship between dihydroetorphine and cholinergic system in the inhibition of respiration and heart rate. Bian CF; Xing SH; Qin W NIDA Res Monogr; 1986; 75():516-9. PubMed ID: 3123971 [TBL] [Abstract][Full Text] [Related]
56. Increased cardiovascular responsiveness to central cholinergic stimulation in the genetically epilepsy-prone rat. Trimarchi GR; Imperatore C; Arcadi FA; Saija A; De Sarro A; De Sarro GB; Costa G J Pharm Pharmacol; 1994 Jun; 46(6):497-502. PubMed ID: 7932046 [TBL] [Abstract][Full Text] [Related]
57. Cardiovascular collapse through non-cholinergic mechanism after intravenous injection of N-methylcarbamate insecticide in rabbits. Futagawa H; Kakinuma Y; Takahashi H Toxicology; 1997 Feb; 117(2-3):163-70. PubMed ID: 9057895 [TBL] [Abstract][Full Text] [Related]
58. Electroencephalographic and behavioral assessment of intracerebroventricular somatostatin and a substance P analogue. Grabow TS; Gaumann DM; Yaksh TL Brain Res; 1989 Jun; 489(2):223-30. PubMed ID: 2472857 [TBL] [Abstract][Full Text] [Related]
59. Difference between the cerebrovascular effect of purinergic Co-ATP and that of the cholinesterase inhibitor, physostigmine, in vivo. Molnár L; Hegedüs K; Fekete I Eur J Pharmacol; 1991 Dec; 209(1-2):81-6. PubMed ID: 1814763 [TBL] [Abstract][Full Text] [Related]